Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.21.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Income Statement [Abstract]    
Revenue
Operating expenses:    
Research and development, net of reimbursements 16,085 16,550
General and administrative 6,308 5,522
Total operating expenses 22,393 22,072
Loss from operations (22,393) (22,072)
Other income:    
Interest income - net 178 172
Total other income 178 172
Net loss (22,215) (21,900)
Deemed dividend for warrant down-round protection provision (1) (1)
Net loss applicable to common stockholders $ (22,216) $ (21,901)
Loss per common share - basic and diluted (in Dollars per share) $ (1.83) $ (4.40)
Weighted average common shares outstanding - basic and diluted (in Shares) 12,134,259 4,975,721